Biomarker Identification for Bladder Cancer Patients
Conditions
Bladder Cancer
Conditions: official terms
Urinary Bladder Neoplasms
Conditions: Keywords
Bladder Cancer
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Intervention
Name: Sample Collection
Type: Procedure
Overall Status
Recruiting
Summary
To develop a simple blood and urine test that we would perform before patients start their treatment to predict the risk that their bladder cancer might come back. To develop this test the investigators plan to analyze blood, urine and cancer tissue from bladder cancer patients and follow them closely during and after treatment. This will include looking for changes in proteins and genes that might play a role in bladder cancer biology. The investigators will then compare the information obtained from the studies of blood, urine and cancer tissue between patients that are cured and those whose cancer comes back. The knowledge about these differences between patients can then potentially be used to develop a blood or urine test to tell us who has a high risk for having bladder cancer come back.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- Adult patients ≥18 years old.

- Patients suspected, clinically diagnosed, or histologically diagnosed bladder cancer.

- Patients undergoing cystoscopy without cancer suspicion.

- Ability to give an informed consent.

Exclusion Criteria:

- Patients receiving concurrent therapy for a second malignancy.

- < 18 years old.

- Inability to give an informed consent.
Location
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Status: Recruiting
Contact: The Ohio State University Comprehensive Cancer Center - 800-293-5066 - Jamesline@osumc.edu
Start Date
January 2014
Sponsors
Ohio State University Comprehensive Cancer Center
Source
Ohio State University Comprehensive Cancer Center
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page